Has anybody been consistently right or wrong about bavi or PPHM? TBD, isn't it?
Peregrine touted their 2nd Line PIIb as a gold-standard trial. It turned out to be a standard screwup for PPHM. Like the HFV government contract that they said they were confident would be renewed; like the PIIb 1st Line trial that read well in December but not in March when independent eyes evaluated the data . . .
I don't say that the current bavi PIII won't return stat. sig. but PPHM has given her critics ample, legitimate cause to be skeptical of the company and, as a result, all of its data. I can't see how anybody could be critical of the PPHM skeptics at this point given PPHM's track record and the sad state of their statistical data going into this PIII.
Market Data 
Markets 
AI
